StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
MDXG

MiMedx Group, Inc.

MDXG Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗
$4.27
+0.14 +3.39%

Key statistics

from XBRL data in SEC filings
Market cap
$622M
Revenue (TTM)
$355M
Net income (TTM)
$6.24M
EPS (TTM)
$0.04
P/E ratio
106.7
Dividend yield
Free cash flow
$72.0M
Cash
$136M
Total assets
$281M
Gross margin
78.8%
52-week range
$3.03 – $7.97

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Results of operations (earnings release); Regulation FD disclosure Jul 29, 2026 10-Q Quarter ended 2026-06-30 Jul 29, 2026 8-K Entered a material agreement; Regulation FD disclosure Jul 29, 2026 8-K Amended charter or bylaws; Shareholder vote results Jun 16, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Apr 29, 2026 10-Q Quarter ended 2026-03-31 Apr 29, 2026 8-K Director or officer change; Regulation FD disclosure Apr 16, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 25, 2026 10-K Fiscal year ended 2025-12-31 Feb 25, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Oct 29, 2025 10-Q Quarter ended 2025-09-30 Oct 29, 2025 8-K Regulation FD disclosure Sep 3, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jul 30, 2025 10-Q Quarter ended 2025-06-30 Jul 30, 2025 8-K Shareholder vote results Jun 20, 2025 8-K Regulation FD disclosure May 13, 2025 10-Q Quarter ended 2025-03-31 Apr 30, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Apr 30, 2025 8-K Regulation FD disclosure Feb 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 26, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025 8-K Regulation FD disclosure Jan 14, 2025 8-K Entered a material agreement Dec 16, 2024 8-K Regulation FD disclosure Nov 18, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Oct 30, 2024 10-Q Quarter ended 2024-09-30 Oct 30, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jul 31, 2024 10-Q Quarter ended 2024-06-30 Jul 31, 2024 8-K Shareholder vote results Jun 7, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Apr 30, 2024 10-Q Quarter ended 2024-03-31 Apr 30, 2024 8-K Regulation FD disclosure Mar 27, 2024 8-K Director or officer change Mar 4, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Feb 28, 2024 10-K Fiscal year ended 2023-12-31 Feb 28, 2024 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Regulation FD disclosure Jan 22, 2024 8-K Other events Dec 28, 2023 8-K Regulation FD disclosure Nov 13, 2023 10-Q Quarter ended 2023-09-30 Oct 30, 2023